Haufinyane tjena, JYMed Technology Co., Ltd. e phatlalalitse hore Leuprorelin Acetate, e hlahisoang ke setsi sa eona sa Hubei JX Bio-Pharmaceutical Co., Ltd., e atlehile ho feta tlhahlobo ea ngoliso ea lithethefatsi.
Tlhaloso ea Pele ea 'Maraka oa Lithethefatsi
Leuprorelin Acetate ke meriana e nang le ente e sebelisoang ho phekola mafu a itšetlehileng ka li-hormone, ka mokhoa oa molek'hule C59H84N16O12•xC2H4O2. Ke gonadotropin-releasing hormone agonist (GnRHa) e sebetsang ka ho thibela tsamaiso ea pituitary-gonadal. Qalong e kopantsoe ke AbbVie le Takeda Pharmaceutical, moriana ona o rekisoa ka tlas'a mabitso a marang-rang a fapaneng linaheng tse fapaneng. United States, e rekisoa tlas'a lebitso la LUPRON DEPOT, ha Chaena, e rekisoa e le Yina Tong.
Hlakola Ts'ebetso le Likarolo Tse Hlalositsoeng Hantle
Ho tloha 2019 ho isa 2022, lipatlisiso le nts'etsopele ea meriana li phethetsoe, tsa lateloa ke ngoliso ea API ka Hlakubele 2024, ha tsebiso ea kamohelo e amoheloa. Tlhahlobo ea ngoliso ea lithethefatsi e fetisitsoe ka Phato 2024. JYMed Technology Co., Ltd. e ne e ikarabella bakeng sa nts'etsopele ea ts'ebetso, nts'etsopele ea mokhoa oa ho hlahloba, lithuto tsa ho se hloeke, ho tiisa sebopeho, le ho netefatsa mokhoa. Hubei JX Bio-Pharmaceutical Co., Ltd. e ne e okametse tlhahiso ea netefatso ea ts'ebetso, netefatso ea mokhoa oa tlhahlobo, le lithuto tsa botsitso bakeng sa API.
Ho Atolosa Mmaraka le Tlhokahalo e Holang
Keketseho e ntseng e eketseha ea mofetše oa tšoelesa ea senya le uterine fibroids e tsamaisa tlhokahalo e ntseng e eketseha ea Leuprorelin Acetate. 'Maraka oa Amerika Leboea hajoale o laola' maraka oa Leuprorelin Acetate, ka litšenyehelo tse ntseng li eketseha tsa tlhokomelo ea bophelo bo botle le kamohelo e phahameng ea mahlale a macha e le tsona tse susumetsang kholo ea kholo. Ka nako e ts'oanang, 'maraka oa Asia, haholo China, o boetse o bonts'a tlhoko e matla ea Leuprorelin Acetate. Ka lebaka la ts'ebetso ea eona, tlhoko ea lefats'e ea sethethefatsi sena e ntse e eketseha, 'me boholo ba mmaraka bo lebelletsoe ho fihla ho $ 3,946.1 milione ka 2031, e bonts'ang sekhahla sa kholo ea selemo le selemo (CAGR) sa 4.86% ho tloha 2021 ho isa 2031.
Mabapi le JYMed
Shenzhen JYMed Technology Co., Ltd. (eo hamorao e tla bitsoa JYMed) e thehiloe ka 2009, e sebetsa ka thata ho etsa lipatlisiso, nts'etsopele, tlhahiso, le thekiso ea li-peptide le lihlahisoa tse amanang le peptide. Ka setsi se le seng sa lipatlisiso le metheo e meraro e meholo ea tlhahiso, JYMed ke e mong oa bahlahisi ba kholo ka ho fetisisa ba li-API tsa peptide tse entsoeng ka lik'hemik'hale Chaena. Sehlopha sa mantlha sa R&D sa k'hamphani se ithorisa ka boiphihlelo ba lilemo tse fetang 20 indastering ea peptide mme se atlehile ho feta tlhahlobo ea FDA habeli. Sistimi e pharalletseng le e sebetsang ea indasteri ea li-peptide ea JYMed e fa bareki mefuta e mengata ea lits'ebeletso, ho kenyelletsa nts'etsopele le tlhahiso ea li-peptide tsa kalafo, li-peptide tsa bongaka ba liphoofolo, li-peptide tse thibelang likokoana-hloko, le li-peptide tsa litlolo, hammoho le ngoliso le tšehetso ea taolo.
Mesebetsi e ka Sehloohong ea Khoebo
1.Ho ngolisoa ha li-peptide ka lapeng le tsa machaba
Li-peptide tsa 2.Veterinary le cosmetic
3.Custom peptides le CRO, CMO, OEM ditshebeletso
Lithethefatsi tsa 4.PDC (peptide-radionuclide, molek'hule e nyane ea peptide, protheine ea peptide, peptide-RNA)
Ntle le Leuprorelin Acetate, JYMed e kentse lifaele tsa ngoliso ho FDA le CDE bakeng sa lihlahisoa tse ling tse 'maloa tsa API, ho kenyelletsa le lithethefatsi tse tsebahalang tsa sehlopha sa GLP-1RA joalo ka Semaglutide, Liraglutide le Tirzepatide. Bareki ba kamoso ba sebelisang lihlahisoa tsa JYMed ba tla khona ho supa ka kotloloho nomoro ea ngoliso ea CDE kapa nomoro ea faele ea DMF ha ba tlisa likopo tsa ho ingolisa ho FDA kapa CDE. Sena se tla fokotsa haholo nako e hlokahalang bakeng sa ho lokisa litokomane tsa kopo, hammoho le nako ea tlhahlobo le litšenyehelo tsa tlhahlobo ea sehlahisoa.
Iteanye le rona
Shenzhen JYMed Technology Co., Ltd.
Aterese:8th&9th Floors, Building 1, Shenzhen Biomedical Innovation Industrial Park, No. 14 Jinhui Road, Kengzi Subtistrict, Pingshan District, Shenzhen
Mohala:+86 755-26612112
Webosaete:http://www.jymedtech.com/
Nako ea poso: Aug-29-2024